CN1840011A - Chinese medicine for treating prostate disease - Google Patents
Chinese medicine for treating prostate disease Download PDFInfo
- Publication number
- CN1840011A CN1840011A CN 200610018161 CN200610018161A CN1840011A CN 1840011 A CN1840011 A CN 1840011A CN 200610018161 CN200610018161 CN 200610018161 CN 200610018161 A CN200610018161 A CN 200610018161A CN 1840011 A CN1840011 A CN 1840011A
- Authority
- CN
- China
- Prior art keywords
- prostate
- jinhuakuizi
- prostatosis
- treatment
- lycopersici esculenti
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 19
- 208000017497 prostate disease Diseases 0.000 title abstract 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims abstract description 40
- 239000000843 powder Substances 0.000 claims abstract description 20
- 235000012054 meals Nutrition 0.000 claims description 19
- 238000011282 treatment Methods 0.000 claims description 19
- 239000006187 pill Substances 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 5
- 239000007901 soft capsule Substances 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 241000227653 Lycopersicon Species 0.000 claims 3
- 229940126678 chinese medicines Drugs 0.000 claims 2
- 240000003768 Solanum lycopersicum Species 0.000 abstract description 37
- 239000011669 selenium Substances 0.000 abstract description 19
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 abstract description 18
- 229910052711 selenium Inorganic materials 0.000 abstract description 18
- 239000000203 mixture Substances 0.000 abstract description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract description 8
- 229930003427 Vitamin E Natural products 0.000 abstract description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract description 4
- 235000019165 vitamin E Nutrition 0.000 abstract description 4
- 229940046009 vitamin E Drugs 0.000 abstract description 4
- 239000011709 vitamin E Substances 0.000 abstract description 4
- 238000009472 formulation Methods 0.000 abstract 1
- 235000020238 sunflower seed Nutrition 0.000 abstract 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 25
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 24
- 235000012661 lycopene Nutrition 0.000 description 24
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 24
- 229960004999 lycopene Drugs 0.000 description 24
- 239000001751 lycopene Substances 0.000 description 24
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 24
- 201000001514 prostate carcinoma Diseases 0.000 description 22
- 230000000694 effects Effects 0.000 description 21
- 238000001035 drying Methods 0.000 description 20
- 239000000047 product Substances 0.000 description 19
- 229940091258 selenium supplement Drugs 0.000 description 19
- 206010028980 Neoplasm Diseases 0.000 description 16
- 238000000034 method Methods 0.000 description 15
- 235000015067 sauces Nutrition 0.000 description 12
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 10
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 10
- 239000012141 concentrate Substances 0.000 description 10
- 201000007094 prostatitis Diseases 0.000 description 10
- 210000002307 prostate Anatomy 0.000 description 8
- 201000011510 cancer Diseases 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 229930003944 flavone Natural products 0.000 description 7
- 235000011949 flavones Nutrition 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 240000005959 Abelmoschus manihot Species 0.000 description 6
- 210000002381 plasma Anatomy 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 235000001642 Hibiscus manihot Nutrition 0.000 description 5
- 206010020880 Hypertrophy Diseases 0.000 description 5
- 206010060862 Prostate cancer Diseases 0.000 description 5
- 230000001093 anti-cancer Effects 0.000 description 5
- 238000013467 fragmentation Methods 0.000 description 5
- 238000006062 fragmentation reaction Methods 0.000 description 5
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 238000001694 spray drying Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 4
- 238000010009 beating Methods 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 208000013507 chronic prostatitis Diseases 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 238000004880 explosion Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000011835 investigation Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 230000001007 puffing effect Effects 0.000 description 4
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 3
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000003064 anti-oxidating effect Effects 0.000 description 3
- 230000000711 cancerogenic effect Effects 0.000 description 3
- 231100000357 carcinogen Toxicity 0.000 description 3
- 239000003183 carcinogenic agent Substances 0.000 description 3
- 235000021466 carotenoid Nutrition 0.000 description 3
- 150000001747 carotenoids Chemical class 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 150000002212 flavone derivatives Chemical class 0.000 description 3
- 150000002213 flavones Chemical class 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000002932 luster Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 210000000582 semen Anatomy 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
- 235000011201 Ginkgo Nutrition 0.000 description 2
- 244000194101 Ginkgo biloba Species 0.000 description 2
- 235000008100 Ginkgo biloba Nutrition 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- -1 flavone compound Chemical class 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000011194 food seasoning agent Nutrition 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 239000007902 hard capsule Substances 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 230000002485 urinary effect Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- RTZMBWHMKICABA-UHFFFAOYSA-N 2-(benzhydryloxymethyl)-4,5-dihydro-1h-imidazole Chemical compound N=1CCNC=1COC(C=1C=CC=CC=1)C1=CC=CC=C1 RTZMBWHMKICABA-UHFFFAOYSA-N 0.000 description 1
- 241001075517 Abelmoschus Species 0.000 description 1
- 235000001075 Abelmoschus manihot Nutrition 0.000 description 1
- 241000554155 Andes Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 108010010256 Dietary Proteins Proteins 0.000 description 1
- 102000015781 Dietary Proteins Human genes 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 206010018866 Haematospermia Diseases 0.000 description 1
- 208000008982 Hemospermia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000233805 Phoenix Species 0.000 description 1
- 108010059820 Polygalacturonase Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 102000007066 Prostate-Specific Antigen Human genes 0.000 description 1
- 108010072866 Prostate-Specific Antigen Proteins 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 208000011622 Testicular disease Diseases 0.000 description 1
- 208000006568 Urinary Bladder Calculi Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003217 anti-cancerogenic effect Effects 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229940093797 bioflavonoids Drugs 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 238000009924 canning Methods 0.000 description 1
- 230000003130 cardiopathic effect Effects 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 230000005754 cellular signaling Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 201000010759 hypertrophy of breast Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 230000007886 mutagenicity Effects 0.000 description 1
- 231100000299 mutagenicity Toxicity 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 235000015205 orange juice Nutrition 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 238000002161 passivation Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 108020004410 pectinesterase Proteins 0.000 description 1
- 210000002640 perineum Anatomy 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 208000022853 pityriasis simplex Diseases 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 208000023958 prostate neoplasm Diseases 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 210000002229 urogenital system Anatomy 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a Chinese medicament for treating prostate diseases, which comprises tomato powder 30-70%, sunflower seed 30-70%, wherein the formulation contains rich Vitamin E and organic selenium.
Description
Technical field
The invention belongs to Chinese medicine, particularly a kind of medicine for the treatment of prostatosis.
Technical background
Prostate hyperplasia also claims optimum hypertrophy of prostate or prostatic hyperplasia, is person in middle and old age man common disease.Patient shows as symptoms such as dysuria, frequent micturition, urine retention, severe patient cause urinate block, urinary system infection, vesical calculus, patient is very painful.Prostatosis is commonly encountered diseases, the frequently-occurring disease that belongs to male genitourinary system.Be divided into acute, chronic two kinds clinically, wherein see with chronic person again more.The chronic prostatitis often state of an illness is longer, and the patient has in various degree frequent micturition, urgent micturition, dysurea and few abdomen, perineum, testis diseases such as weighing down expand sense or sexual hypofunction, seminal emission, premature ejaculation, hemospermia, pain.At present, the treatment of prostatitis and prostatic hyperplasia still there is not specific short.All kinds of antibiotic and urinary system anti-infective, though prostatitis is had certain short term effect, relapse rate is high, it is difficult to cure after the formation chronic prostatitis.It is once voguish both at home and abroad in the 30-50 age that the Drug therapy of prostatic hyperplasia is used estrogen, still has the people to use so far.Also really can the respite dysuria, but that side effect is a gastrointestinal reaction is very big, influences appetite, breast hypertrophy pain discomfort.So after the seventies, clinical few the using that be tending towards trying one's best.Widely apply diphenazoline etc. that prostatic hyperplasia patient long-term (about 5 years) is used in recent years abroad, receive rather satisfied effect, but very big to the influence of blood pressure.So hypertension and cardiopathic patient forbidding is arranged.And with the logical price comparison costlinesses such as (Germany's systems) of the urine of this medicine and import, be difficult to promote.Chinese medicine is the valuable cultural heritage of the Chinese nation, at aspects such as treatment commonly encountered diseases, frequently-occurring disease, difficult and complicated illness its special effect is arranged.Advantage more and more is subjected to attracting attention of common people to Chinese medicine because of its special effect, toxic and side effects be little etc.At present, the Chinese patent medicine that is used for the treatment of chronic prostatitis is more, as prostatitis return of spring capsule, qian lie tong yu jiao nang, QIANLIEKANG PIAN etc., the treatment chronic prostatitis is had certain effect, but effect is remarkable inadequately, cure rate is lower.
Summary of the invention:
The object of the present invention is to provide a kind of Chinese medicine for the treatment of prostatosis, have that dampness removing is treating stranguria, an effect of blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, vital energy benefiting and the kidney invigorating, not only improved therapeutic effect, also have life lengthening, antidotal effect.
Solution of the present invention is that the Chinese medicine of treatment prostatosis contains tomato meal 30%-70%, JINHUAKUIZI powder 30%-70%.
Fructus Lycopersici esculenti, its Fructus Lycopersici esculenti cries in the north.Originate in Andes one band of South America, Fructus Lycopersici esculenti can be used as fruit and eats something rare, and can be used as dish again and burns soup, goes back sauce producing, system juice, the processing canning.The versatility of Fructus Lycopersici esculenti grows with each passing day its status on market.With Vitamin C content, be about 19 milligrams in the 100 gram fresh fruits.Research recently points out that Fructus Lycopersici esculenti contains abundant flavonoids, is exactly the flavone compound with nutritional activities as lycopene, has the function of angiocardiopathy preventing and tumor.
The effect that Fructus Lycopersici esculenti has the prevention carcinoma of prostate mainly has benefited from making Fructus Lycopersici esculenti to present red lycopene.Lycopene is a kind of natural pigment composition in the food, belongs to carotenoid on chemical constitution.It is a polyphenoils the strongest in the carotenoid, and the ability of removing active oxygen is 10 times of vitamin E.Lycopene can not synthesize in human body, must be from food supply, and mainly from Fructus Lycopersici esculenti and products thereof, as tomato sauce, Fructus Lycopersici esculenti juice etc., wherein the bioavailability of tomato sauce (with oily Fructus Lycopersici esculenti of boiling) is higher than fresh tomato.Present people have worked out it to be had antioxidation, mutation inhibiting, reduction nucleic acid damaging, reduces multiple functions such as cardiovascular disease and prophylaxis of cancer.As far back as the 1950's, the medical expert of the U.S. has anticarcinogenic effect with regard to the reported first lycopene.Afterwards, Epidemiological study and clinical research proved that lycopene had prevention and suppresses the effect of cancer.Wherein, lycopene prevention carcinoma of prostate is the maximum field of research.
U.S. Harvard Medical School has delivered absorbs the epidemiological study that tomato products can reduce the carcinoma of prostate sickness rate.They have carried out reaching the follow-up investigation (1986-1998) in 12 years to 51529 male.The questionnaire survey result who begins most shows, often eats the male that tomato sauce, Fructus Lycopersici esculenti juice, Fructus Lycopersici esculenti, pizza etc. are rich in the tomato products of lycopene and reduced 35% than the danger that the male who seldom eats tomato products suffers from carcinoma of prostate.Follow-up investigation is the result after 6 years and 12 years show, it is still lower that the male who often eats tomato products suffers from the danger of carcinoma of prostate, but the reduction amount has only 17% and 16% respectively.It is to be noted that especially former result of study shows that after tomato products boiled, the bioavailability of lycopene increased, therefore the biological effect of the tomato products that boils is stronger.Initial questionnaire survey result shows, often eat the danger reduction by 44% that tomato sauce can make the male suffer from carcinoma of prostate, and the result of follow-up investigation after 12 years shows, eats twice tomato sauce weekly at least and can make the male suffer from the danger reduction by 23% of carcinoma of prostate.They infer that this may be because oil or fat promote the absorption of lycopene in the tomato sauce.For example, the protective effect on cancer risk of Fructus Lycopersici esculenti juice itself is not remarkable, because the lycopene of its inside be difficult to absorb, still, if take in just significantly rising of lycopene levels in the blood in the 24h again after with oil Fructus Lycopersici esculenti juice being boiled.The researcher of Illinois, USA university reports that recently tomato sauce can slow down even reverse carcinoma of prostate.They are diagnosed as the patient of carcinoma of prostate to 32 examples, and in 3 weeks before undergoing surgery, grouping has carried out taking tomato sauce that contains the 30mg lycopene and the clinical observation of not taking tomato sauce.When being carried out pathologic finding, the prostate of extracing finds after 3 weeks, every patient who takes tomato sauce, and 4 carcinoma markers all change: the aggressive of cancerous cell performance is less; The prostate specific antigen level reduces; Gross tumor volume dwindles; Tumor forms the level reduction in the prostatic epithelium.And in not taking the tomato sauce group, the variation that above-mentioned mark is not all got better.Prove that thus lycopene truly has anti-cancer, controls the effect of cancer.
Observed the influence of whole tomato meal and lycopene at present, found that suffering from the dangerous of carcinoma of prostate with whole tomato meal rat feeding significantly reduces by 26%, and obviously do not improve with pure lycopene rat feeding to carcinogen and HORMONE TREATMENT rat.Multiple nutrients matter interaction in the food more helps bringing into play the positive effect of nutrient substance.And, in extracting pure nutrient substance process, because food is handled absorption and the availability that has reduced nutrient substance itself on the contrary.
The mechanism of action of lycopene prevention or treatment carcinoma of prostate has many aspects.Some researcheres are thought the non-oxidizability that at first will give the credit to it.Lycopene can be caught peroxylradicals, thereby prevent lipid, lipoprotein, protein and DNA oxidation by physics and chemical mode quenching singlet oxygen.Though most carotenoid all are effective anti-oxidants, the activity of lycopene cancellation singlet oxygen is the strongest, and it is the abundantest carotene of content in the prostate.Secondly, one of important mechanisms that tumor generates is that histiocyte under the effect of extraneous mutagenic agent gene mutation takes place, and lycopene can be blocked this process, the performance antitumaous effect.In addition, there are some researches show that also lycopene can suppress the cancer cell multiplication of Induced by IGF.At home, the production of lycopene and research all be in the starting stage and external gap also very big.China's approved contains the health food listing of " lycopene " functional component at present.
Hibiscus manihot L., formal name used at school Abelmoschus manihot (L.) Malvaceae Abelmoschus, draft is annual.Vertical growth, multi-branched, dark green leaf color splits to lack and slaps shape; 16-18 centimetre of flower foresythia , the column inflorescence, the stamen milky white, the gynoecium Fructus Jujubae is red; Petal base portion hyacinthine near inflorescence forms seductive brilliant round string circle, and alabastrum is bloomed from bottom to top in the branch alternate, self-flowering fruiting, north fruit, nearly vertebra shape, by green gradually yellow, the period of maturation is pitch-black, the sharp hair of the many whites of shell, ripe cracking five lobes of seed, the seed subcircular, dark brown is about mass of 1000 kernel 20 grams.Natural Vitamin E content, natural biological flavones content are that content is the highest in known plants now, and protein, dietary fiber are of high grade, and selenium, zinc, ferrum, calcium, potassium content are higher.It is an important new discovery that JINHUAKUIZI core is extracted biological general flavone, and the flavones content shelter has first of the flavone of the containing plant, makes common people shock.Simultaneously, VC, albumen, polysaccharide glue, the necessary trace element of human bodies such as Plant fiber, not saponification mineral selenium, ferrum, zinc is also extremely abundant.
Hibiscus manihot L. is easily planted, and adaptability is very strong, does not select soil, and is drought-enduring waterlogging; From being seeded into results only 130 days.Planted experimentally successfully on Enshi City dragon and phoenix dam, Hubei Province by these several years.Entrusted Sino-Japan food research center that JINHUAKUIZI core has been done the active ingredient detection in 2004.Prove that every gram contains total flavones up to 26.013 milligrams, seed core contains the VE0.68 milligram.After testing, the Hibiscus manihot L. Se content of results reaches 2.7ppm (this experimental plot Se content is 0.56ppm).Before this, universally acknowledged Semen Ginkgo and daidzein content are the highest, and newfound Hibiscus manihot L. exceeds tens times of Semen Ginkgo and Semen sojae atricolor.VE content exceeds 2000 times in milk, 3000 times of fresh orange-juices.At present, the plant of any extraction flavone is beyond challenge.In human and animal's body and in vitro tests studies show that flavonoid has many potential promotion health benefits, comprise effects such as antiallergic, antiinflammatory, antiviral, anticancer, anti-cancer, blood sugar lowering, blood fat reducing and antioxidation.It can prevent cytotoxicity and the tissue injury that human multiple disease that oxygen-derived free radicals and hydride bring out causes as antioxidant.Bioflavonoids has superpower oxidation resistance, is safeguarding people's blood circulation normal function, is improving and to play special role aspect the body immunity.The mechanism of VE prevention effect on prostate carcinoma comprises: antioxidation, suppress prostate gland cancer cell propagation and promote cancer cell-apoptosis etc.
Selenium is one of most important essential trace element of mammal, life processes such as the anti-oxidative defense of participation body, cell signalling, hormonal regulation.It is higher 4 to 5 times than the male that blood plasma selenium level is higher than 0.107 μ g/ml that blood plasma selenium level is lower than the danger that the male of 0.107 μ g/ml suffers from carcinoma of prostate.Recently, the research of U.S. Harvard Medical School has further confirmed the relation of selenium and carcinoma of prostate.Their this research has carried out reaching the follow-up investigation in 13 years since nineteen eighty-two to 22000 male, analyzing and testing 586 patients with prostate cancer and 577 contrast crowds' blood plasma selenium and prostate-specific antibody horizontals.The result shows, blood plasma selenium level and trouble prostate cancer risk negative correlation, and this dependency is especially remarkable in the higher crowd of prostate specific antibody level.Be higher than among the crowd of 4ng/ml in prostate specific antibody level, blood plasma selenium level is suffered from prostatic danger the experimenter of 0.12-0.19ppm and is reduced by 50% than blood plasma selenium level the experimenter of 0.06-0.09ppm.And be higher than among the crowd of 10ng/ml in prostate specific antibody level, high selenic experimenter suffers from prostatic dangerous reduction by 70%.They think that these results show selenium to the obvious effect of not having of carcinoma of prostate, but can effectively slow down the development of carcinoma of prostate.
Based on body selenium level and the negative correlation of suffering from prostate cancer risk, certain cancers nutrition prophylactic tria has been investigated selenium supplement to carcinoma of prostate generation Influence and Development.The result shows that selenium supplement can prevent carcinoma of prostate fruitfully.Selenium antitumaous effect mechanism may for: 1) strengthen the activity of selenoenzymes such as glutathione peroxidase, prevent the normal cell oxidative damage; 2) regulate body immune system, strengthen human immune system's anti-cancer ability; 3) anticancer propagation; 4) promote cancer cell-apoptosis; 5) change the metabolism of carcinogen, thereby reduce the mutagenicity of carcinogen.
Test confirms that the Hibiscus manihot L. of being planted is the high-quality kind that is rich in selenium, VE on the rich selenium soil of bestowing favour, be the quality raw materials of producing high-grade health product and medicine.Tomato meal and JINHUAKUIZI core powder can be made clinical acceptable peroral dosage form by prescription comprise oral liquid, tablet, capsule, soft capsule, granule, medicated wine, pill, powder etc.
The processing process of tomato meal is: Fructus Lycopersici esculenti → cleaning → selection → heat fragmentation → making beating → vacuum concentration → drying
(1) material choice: the Fructus Lycopersici esculenti of selecting fresh, ripe, color and luster azarin, no disease and pest for use is as raw material.
(2) clean: remove silt, residual pesticide and the microorganism etc. of adhering on the fruit.
(3) selection: remove rotten, ill pityriasis simplex or the bad Fructus Lycopersici esculenti of color and luster.
(4) heat is broken: the breaking method of Fructus Lycopersici esculenti comprises hot fragmentation and cold fragmentation.Hot fragmentation is meant the processing method that will be heated to 85 ℃ after the Fructus Lycopersici esculenti fragmentation immediately.Because hot crush method can obtain passivation timely with pectinesterase in the strained tomatoes and polygalacturonase, pectin substance reservation amount is many, and last gained tomato product has higher denseness.
(5) making beating: the purpose of making beating is for the skin of removing Fructus Lycopersici esculenti and seed.Adopt two pass or three road beaters to pull an oar, the mesh size of the first road beater is 0.8～1.0 centimetre, and the mesh size of the second road beater is generally 0.4～0.6 centimetre.The rotating speed of beater is generally 800～1200 rev/mins.The making beating back gained skin quantity of slag generally should be controlled at 4%～5%.
(6) vacuum concentration: spissated method has vacuum concentration and normal pressure to concentrate.Normal pressure concentrates owing to spissated temperature height, and the Fructus Lycopersici esculenti slurry is heated and can causes color and luster, local flavor to descend poor product quality; And the temperature that vacuum concentration adopted is about 50 ℃, and vacuum is more than 670 millimetress of mercury.
(7) drying means of the dry Fructus Lycopersici esculenti concentrate of Fructus Lycopersici esculenti concentrate is a lot, mainly contains freeze-drying, explosion puffing drying method, cylinder drying, froth bed seasoning and spray drying method etc.
(1) freeze-drying: this method is to adopt low temperature that the Fructus Lycopersici esculenti concentrate is freezed, and moisture distils and carries out drying under high vacuum state then.The gained Fructus Lycopersici esculenti still keeps their original structures, and does not damage its original shape and size.Therefore, cryodesiccated granule has loose structure, is keeping the occupied space of former cause moisture and does not subside, thereby helping the rapid rehydration of product.But this method energy consumption is big, and freeze drying equipment is very expensive, thus the product cost height that obtains.
(2) explosion puffing drying method: the explosion puffing drying method utilizes explosion puffing drying equipment to carry out the drying of Fructus Lycopersici esculenti concentrate.Usually need the absolute pressure of 2.6 millimetress of mercury to dewater, Fructus Lycopersici esculenti concentrates material temperature and is generally 60～70 ℃.For the moisture that makes final products reaches 3%, be generally 90 minutes to 5 hours drying time.Wanted earlier product to be cooled down before removing vacuum, subside to avoid the product leavening structure, this is because the tomato meal of gained is thermoplastic.Tomato meal structure by this method preparation is harder, and volume and concentrate volume differences are few, product rehydration poor performance.In addition, expanded must under vacuum condition, carrying out, cost is than higher, thereby causes the price comparison costliness of product.
(3) spray drying method: before spray drying, should concentrate slurry to Fructus Lycopersici esculenti earlier and carry out the homogenizing processing.Homogenization pressure is generally 150～200 kilograms/square centimeter.The general tower cornice that adopts has the centrifugal or two fluid-type spray dryers of cooling jacket (double-deck tower wall can utilize the temperature of air cooling hothouse inwall) to carry out drying; If heat medium is the dry air that dehumidifies through in advance, the inlet temperature when so dry is generally about 150～160 ℃, and leaving air temp is 77～85 ℃, and input concentration is generally 20%～30%.
There has been the spray drying device of some remodeling can be used for processing the fruit and vegerable powder on the market now.Some are to utilize air as dry gas, adopt 75～95 ℃ medium inlet temperature to carry out drying, thereby can improve speed of production; Other are that profit is got rid of the dehydration air as dry gas, and (25-50 ℃) carries out drying under lower inlet temperature.But it is all very high that all these are used for the body of the tower of spray drying device of dry Fructus Lycopersici esculenti, thereby required expense increases when setting up a factory.
(4) froth bed seasoning: the key of this drying means mainly is to resemble foamers such as soybean protein, globulin, fatty acid ester, sugar ester and glyceryl monostearate by interpolation to form stable foam in the Fructus Lycopersici esculenti concentrate.Gas temperature in logical people's exsiccator is approximately 93 ℃, and speed is approximately 100～130 meter per seconds, adds in the mode of adverse current.Be decided by product characteristics and employed drying condition drying time, be 15～18 minutes general drying time.
(5) cylinder is in dry method: the rotating speed of cylinder is generally 3.5 changes per minutes, and steam pressure is 3.5 kilograms/square centimeter, and the spacing between the cylinder is 0.2 millimeter.The water vapour that produces when making drying can be taken away rapidly, needs bubbling air, and the air-flow of feeding is opposite with the direction of rotation of cylinder, i.e. adverse current feeding; And the air in control material collection district is 15%～20% to humidity.But this drying means can not really reach the purpose of dry tomato meal.Because the product moisture content that obtains is at least 7%, need under 20 ℃ of conditions, continue with pneumatic conveying drying more than 24 hours.Otherwise, moisture be product more than 7% in storage, its color, local flavor and nutritive value all will seriously descend.
The processing process of JINHUAKUIZI powder is: JINHUAKUIZI core selection → pulverizing → microwave sterilizating → JINHUAKUIZI core powder
(1) material choice: select for use ripe exsiccant JINHUAKUIZI core as raw material.
(2) selection: remove JINHUAKUIZI core rotten, ill worm.
(3) pulverize: JINHUAKUIZI core is pulverized.
(4) microwave sterilizating: the JINHUAKUIZI core powder of pulverizing is got final product with microwave sterilizating.
The invention has the beneficial effects as follows: the present invention adopts a kind of plant-JINHUAKUIZI core powder and tomato meal prescription that is rich in dimension E and organic selenium, have the advantage of the direct compatibility of former plant, and the main function element is organic, the easier absorption of human body, safer.The treatment prostatosis, it is easy to have a Therapeutic Method, has no side effect, and patient's no pain need can not treated the cure rate height in hospital.
The prescription that uses in test is with tomato meal content 50%, JINHUAKUIZI core powder 50% at present.Mix homogeneously is processed as tablet, the 2.5g/ sheet.Through chemical examination, contain lycopene 0.25mg/ sheet, vitamin E 0.8mg/ sheet, organic selenium 4.7 μ g/ sheets.Above preparation is through the urology department clinical trial of Enshi City central hospital, the time: year June in June, 2004-2005, total case 10 examples, age 56-85 year, average 65 years old, prostatitis 3 examples wherein, benign prostatic hyperplasia 5 examples, carcinoma of prostate 2 examples.I degree hypertrophy 2 examples, II degree hypertrophy 2 examples, III degree hypertrophy 1 example among the benign prostatic hyperplasia person.Method of administration: each 5.0g, every day 2 times.After taking 3 months, prostatitis patient 3 example recoveries from illness, benign prostatic hyperplasia 5 examples are all effective, and body of gland obviously dwindles.2 routine carcinoma of prostate patient tumors do not have significant change.After taking 6 months, prostatic hyperplasia patient 4 examples return to normal level 4 * 3 * 2cm, and III degree hypertrophy patient body of gland is reduced to 5.5 * 3.8 * 3cm, and the carcinoma of prostate patient tumors is obviously dwindled, and reduces to φ 1.2cm, φ 1.5cm from φ 1.8cm, φ 2.0cm respectively.After taking medicine 10 months, benign prostatic hyperplasia patient full recovery is normal, and carcinoma of prostate the patient detect through color ultrasound, and 1 routine tumor disappears, and 1 routine tumor is reduced to φ 0.5cm.Clinical confirmation, this prescription has 100% cure rate to prostatitis, benign prostatic hyperplasia, to tumor of prostate effective percentage 100%, cure rate 50%.
The specific embodiment
Embodiment one:
Get tomato meal 5000 grams respectively, JINHUAKUIZI core powder 5000 grams.Mix homogeneously, tabletting is made 4000, promptly gets our tablet.
Embodiment two:
Get tomato meal 3000 grams respectively, JINHUAKUIZI core powder 7000 grams.Mix homogeneously is dressed up in 20000 hard capsules, promptly gets our hard capsule.
Embodiment three:
Get tomato meal 7000 grams respectively, JINHUAKUIZI core powder 3000 grams.Mix homogeneously is dressed up in 50000 soft capsules, promptly gets our soft capsule.
Embodiment four:
Get tomato meal 4500 grams respectively, JINHUAKUIZI core powder 5500 grams.Mix homogeneously adds an amount of Mel, makes 4000 pills, promptly gets our pill.
Embodiment five:
Get tomato meal 5500 grams respectively, JINHUAKUIZI core powder 4500 grams.Mix homogeneously adds an amount of Mel, makes 4000 pills, promptly gets our pill.
Embodiment six:
Get tomato meal 5100 grams respectively, JINHUAKUIZI core powder 4900 grams.Mix homogeneously is dressed up in 20000 capsules, promptly gets our capsule.
Claims (4)
1, a kind of Chinese medicine for the treatment of prostatosis is characterized in that containing tomato meal 30%-70%, JINHUAKUIZI powder 30%-70% in the medicine of described treatment prostatosis.
2, want 1 described a kind of Chinese medicine for the treatment of prostatosis according to right, it is characterized in that containing tomato meal 40%-60%, JINHUAKUIZI powder 40%-60% in the medicine of described treatment prostatosis.
3, want 1 or 2 described a kind of Chinese medicines for the treatment of prostatosis according to right, it is characterized in that containing tomato meal 45%-55%, JINHUAKUIZI powder 45%-55% in the medicine of described treatment prostatosis.
4, want 1 or 2 described a kind of Chinese medicines for the treatment of prostatosis according to right, the medicine that it is characterized in that described treatment prostatosis is made clinical acceptable peroral dosage form and is comprised oral liquid, tablet, capsule, soft capsule, granule, pill, powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200610018161 CN1840011A (en) | 2006-01-09 | 2006-01-09 | Chinese medicine for treating prostate disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200610018161 CN1840011A (en) | 2006-01-09 | 2006-01-09 | Chinese medicine for treating prostate disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1840011A true CN1840011A (en) | 2006-10-04 |
Family
ID=37029314
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200610018161 Pending CN1840011A (en) | 2006-01-09 | 2006-01-09 | Chinese medicine for treating prostate disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1840011A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2223608A4 (en) * | 2007-10-22 | 2010-12-08 | Beijing Dongsheng Agricultural | PRODUCT BASED ON THE ABELMOSCHUS MANIHOT MEDICUS ENVELOPE AS A RAW MATERIAL FOR AN EDIBLE AND PHARMACEUTICAL PRODUCT |
| CN105434684A (en) * | 2015-12-31 | 2016-03-30 | 河南弘烨生物科技有限公司 | Abelmoschus manihot flower containing traditional Chinese medicine preparation for preventing and treating prostate disease and preparation method of traditional Chinese medicine preparation |
| CN105560308A (en) * | 2015-12-31 | 2016-05-11 | 河南弘烨生物科技有限公司 | Application of Flower of Hibiscus manihot L. in preparation of products for preventing and treating prostate diseases |
| CN105616511A (en) * | 2015-12-31 | 2016-06-01 | 河南弘烨生物科技有限公司 | Bagged tea capable of preventing and treating prostate disease and preparation method thereof |
| CN108524713A (en) * | 2018-07-05 | 2018-09-14 | 天津益倍元天然产物技术有限公司 | Improve the functional composition and its preparation method and application of male prostate health |
-
2006
- 2006-01-09 CN CN 200610018161 patent/CN1840011A/en active Pending
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2223608A4 (en) * | 2007-10-22 | 2010-12-08 | Beijing Dongsheng Agricultural | PRODUCT BASED ON THE ABELMOSCHUS MANIHOT MEDICUS ENVELOPE AS A RAW MATERIAL FOR AN EDIBLE AND PHARMACEUTICAL PRODUCT |
| CN105434684A (en) * | 2015-12-31 | 2016-03-30 | 河南弘烨生物科技有限公司 | Abelmoschus manihot flower containing traditional Chinese medicine preparation for preventing and treating prostate disease and preparation method of traditional Chinese medicine preparation |
| CN105560308A (en) * | 2015-12-31 | 2016-05-11 | 河南弘烨生物科技有限公司 | Application of Flower of Hibiscus manihot L. in preparation of products for preventing and treating prostate diseases |
| CN105616511A (en) * | 2015-12-31 | 2016-06-01 | 河南弘烨生物科技有限公司 | Bagged tea capable of preventing and treating prostate disease and preparation method thereof |
| CN105560308B (en) * | 2015-12-31 | 2019-11-01 | 河南弘烨生物科技（集团）有限公司 | Flower of JINHUAKUI is preparing the application in the product for preventing and treating prostatic disorders |
| CN108524713A (en) * | 2018-07-05 | 2018-09-14 | 天津益倍元天然产物技术有限公司 | Improve the functional composition and its preparation method and application of male prostate health |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102287247B1 (en) | The composition of joint nutritional supplement for companion animals | |
| CN104479946A (en) | Method for preparing nutrient alcoholic drink mixed with fruit juice from hibiscus esculentus-fungus-algae plant composition | |
| KR101837158B1 (en) | Meat sauce using fermented rice bran products and manufacturing method thereby | |
| CN1602758A (en) | Nutritious liquor (drink) for relieving the effect of alcohol, alcohol relieving capsule production method | |
| CN104479964A (en) | Hibiscus esculentus-fungus-algae health wine and preparation method thereof | |
| CN104473286A (en) | Solid (functional) beverage synthesized from hibiacus esculengtus, fungi and alga and preparation method thereof | |
| CN107319242A (en) | L-cn effervescent tablet for slimming and preparation method thereof | |
| JP2004331641A (en) | Mixed food obtained by adding lignin, tannin, persimmon tannin, or the like, into bracket fungal spore, feed additive and anti-pneumonia virus agent | |
| CN103262980A (en) | Selenium germanium chromium elements-enriched vitamin spirulina health-care rice flour | |
| CN103396251A (en) | High-selenium-germanium body building and strengthening sweet potatoes | |
| CN1840011A (en) | Chinese medicine for treating prostate disease | |
| JP2001199892A (en) | Method for enhancing anti-tumor activity of amygdalin-containing substance, composition containing anti-tumor activity-enhancing amygdalin-containing substance, method for evaluating anti-tumor efficacy of treatment with amygdalin-containing substance, and method for evaluating anti-tumor efficacy of amygdalin-containing substance | |
| CN101797049B (en) | Nutrient eight-treasure soup formula and preparation process thereof | |
| CN111387345A (en) | Compound polysaccharide composition and preparation method thereof | |
| KR101253342B1 (en) | Dry flavor composition of new flavor containing vitamin and preparation method | |
| CN101007055B (en) | Preparation method of eucommia pollen soft capsule rich in α-linolenic acid | |
| CN104430720A (en) | Method for making functional biscuits through okra, fungus and algae plant mixtures | |
| CN103385465A (en) | Natural green element convenient rice | |
| CN103169742A (en) | Application of elaeagnus conferta roxb | |
| CN107496473A (en) | Application of the okra water extract in digestive tract function is protected | |
| KR101093006B1 (en) | Method for producing functional health food containing bezoar bovis used microbes and the functional health food produced by the same | |
| CN112042846A (en) | Sea-buckthorn solid beverage for enhancing immunity and inhibiting tumors and preparation method thereof | |
| KR101925124B1 (en) | Manufacturing method for fermented drink using vegetable sourse | |
| CN113501858A (en) | Method for extracting buckwheat micromolecule peptide liquid and peptide powder by electromagnetic cracking technology | |
| CN113040392A (en) | Composite preparation containing ovalbumin peptide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |